{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:26:52Z","timestamp":1793820412781,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10549-025-07643-4","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T09:56:31Z","timestamp":1740390991000},"page":"507-519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice"],"prefix":"10.1007","volume":"210","author":[{"given":"Miriam","family":"Potrony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blai","family":"Morales-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Badenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Villanueva-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Montalb\u00e1n-Casafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Arnau-Collell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ramon y Cajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Arag\u00f3n Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Carrasco Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Cebrecos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gonz\u00e1lez-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ferrer-Mileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Rodriguez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Gaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Oriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Anton","family":"Puig-Butill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"7643_CR1","unstructured":"Petrucelli N, Daly MB, Pal T (2022) BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. GeneReviews\u00ae"},{"key":"7643_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg \u00c5, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130. https:\/\/doi.org\/10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"7643_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22073753","author":"MT Vietri","year":"2021","unstructured":"Vietri MT, D\u2019elia G, Caliendo G, Resse M, Casamassimi A, Passariello L, Albanese L, Cioffi M, Molinari AM (2021) Hereditary prostate cancer: genes related, target therapy and prevention. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS22073753","journal-title":"Int J Mol Sci"},{"key":"7643_CR4","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA, Noll WW (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222\u20132233. https:\/\/doi.org\/10.1002\/cncr.24200","journal-title":"Cancer"},{"key":"7643_CR5","doi-asserted-by":"publisher","DOI":"10.15761\/icst.1000228","author":"I Godet","year":"2017","unstructured":"Godet I, M Gilkes D (2017) BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. https:\/\/doi.org\/10.15761\/icst.1000228","journal-title":"Integr Cancer Sci Ther"},{"key":"7643_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333. https:\/\/doi.org\/10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"key":"7643_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1155\/2020\/9873954","volume":"2020","author":"B Dullens","year":"2020","unstructured":"Dullens B, De Putter R, Lambertini M, Toss A, Han S, Van Nieuwenhuysen E, Van Gorp T, Vanderstichele A, Van Ongeval C, Keupers M, Prevos R, Celis V, Dekervel J, Everaerts W, Wildiers H, Nevelsteen I, Neven P, Timmerman D, Smeets A, Denayer E, Van Buggenhout G, Legius E, Punie K (2020) Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1\/2: a review of secondary prevention guidelines. J Oncol 2020:13","journal-title":"J Oncol"},{"key":"7643_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/nejmoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittom\u00e4ki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KBM, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King M-C, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497\u2013506. https:\/\/doi.org\/10.1056\/nejmoa1400382","journal-title":"N Engl J Med"},{"key":"7643_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/JCO.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Leei A, Adank MA, Adlard J, Aittom\u00e4ki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg \u00c5, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, De Pauw A, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Golmard L, Goode EL, Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarland R, McKinnon W, Meindl A, Metcalfe K, Taib NAM, Moilanen J, Nathanson KL, Neuhausen S, Ng PS, Nguyen-Dumont T, Nielsen SM, Obermair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylk\u00e4s K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte AB, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, Van Overeem HT, Whitworth J, Wood M, Yip CH, Yoon SY, Yussuf A, Zogopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balma\u00f1a J, Houdayer C, James P, El-Haffaf Z, Ehrencrona H, Janatova M, Peterlongo P, Nevanlinna H, Schmutzler R, Teo SH, Robson M, Pal T, Couch F, Weitzel JN, Elliott A, Southey M, Winqvist R, Easton DF, Foulkes WD, Antoniou AC, Tischkowitz M (2020) Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol 38:674\u2013685. https:\/\/doi.org\/10.1200\/JCO.19.01907","journal-title":"J Clin Oncol"},{"key":"7643_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/nejmoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, Wahlstr\u00f6m C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, \u00c1lvarez N, Herraez B, Fernandez V, N\u00fa\u00f1ez-Torres R, Osorio A, Valcich J, Li M, T\u00f6rngren T, Harrington PA, Baynes C, Conroy DM, Decker B, Fachal L, Mavaddat N, Ahearn T, Aittom\u00e4ki K, Antonenkova NN, Arnold N, Arveux P, Ausems MGEM, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, Bia\u0142kowska K, Blomqvist C, Bogdanova NV, Bogdanova-Markov N, Bojesen SE, Bonanni B, B\u00f8rresen-Dale A-L, Brauch H, Bremer M, Briceno I, Br\u00fcning T, Burwinkel B, Cameron DA, Camp NJ, Campbell A, Carracedo A, Castelao JE, Cessna MH, Chanock SJ, Christiansen H, Coll\u00e9e JM, Cordina-Duverger E, Cornelissen S, Czene K, D\u00f6rk T, Ekici AB, Engel C, Eriksson M, Fasching PA, Figueroa J, Flyger H, F\u00f6rsti A, Gabrielson M, Gago-Dominguez M, Georgoulias V, Gil F, Giles GG, Glendon G, Garcia EBG, Aln\u00e6s GIG, Gu\u00e9nel P, Hadjisavvas A, Haeberle L, Hahnen E, Hall P, Hamann U, Harkness EF, Hartikainen JM, Hartman M, He W, Heemskerk-Gerritsen BAM, Hillemanns P, Hogervorst FBL, Hollestelle A, Ho WK, Hooning MJ, Howell A, Humphreys K, Idris F, Jakubowska A, Jung A, Kapoor PM, Kerin MJ, Khusnutdinova E, Kim S-W, Ko Y-D, Kosma V-M, Kristensen VN, Kyriacou K, Lakeman IMM, Lee JW, Lee MH, Li J, Lindblom A, Lo W-Y, Loizidou MA, Lophatananon A, Lubi\u0144ski J, MacInnis RJ, Madsen MJ, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Maurer T, Mavroudis D, McLean C, Meindl A, Mensenkamp AR, Michailidou K, Miller N, Mohd Taib NA, Muir K, Mulligan AM, Nevanlinna H, Newman WG, Nordestgaard BG, Ng P-S, Oosterwijk JC, Park SK, Park-Simon T-W, Perez JIA, Peterlongo P, Porteous DJ, Prajzendanc K, Prokofyeva D, Radice P, Rashid MU, Rhenius V, Rookus MA, R\u00fcdiger T, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Sch\u00fcrmann P, Shah M, Sohn C, Southey MC, Surowy H, Suvanto M, Thanasitthichai S, Tomlinson I, Torres D, Truong T, Tzardi M, Valova Y, van Asperen CJ, Van Dam RM, van den Ouweland AMW, van der Kolk LE, van Veen EM, Wendt C, Williams JA, Yang XR, Yoon S-Y, Zamora MP, Evans DG, de la Hoya M, Simard J, Antoniou AC, Borg \u00c5, Andrulis IL, Chang-Claude J, Garc\u00eda-Closas M, Chenevix-Trench G, Milne RL, Pharoah PDP, Schmidt MK, Spurdle AB, Vreeswijk MPG, Benitez J, Dunning AM, Kvist A, Teo SH, Devilee P, Easton DF (2021) Breast cancer risk genes \u2014 Association analysis in more than 113,000 women. N Engl J Med 384:428\u2013439. https:\/\/doi.org\/10.1056\/nejmoa1913948","journal-title":"N Engl J Med"},{"key":"7643_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/nejmoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, Gao C, Lilyquist J, Yadav S, Boddicker NJ, Samara R, Klebba J, Ambrosone CB, Anton-Culver H, Auer P, Bandera EV, Bernstein L, Bertrand KA, Burnside ES, Carter BD, Eliassen H, Gapstur SM, Gaudet M, Haiman C, Hodge JM, Hunter DJ, Jacobs EJ, John EM, Kooperberg C, Kurian AW, Le Marchand L, Lindstroem S, Lindstrom T, Ma H, Neuhausen S, Newcomb PA, O\u2019Brien KM, Olson JE, Ong IM, Pal T, Palmer JR, Patel AV, Reid S, Rosenberg L, Sandler DP, Scott C, Tamimi R, Taylor JA, Trentham-Dietz A, Vachon CM, Weinberg C, Yao S, Ziogas A, Weitzel JN, Goldgar DE, Domchek SM, Nathanson KL, Kraft P, Polley EC, Couch FJ (2021) A population-based study of genes previously implicated in breast cancer. N Engl J Med 384:440\u2013451. https:\/\/doi.org\/10.1056\/nejmoa2005936","journal-title":"N Engl J Med"},{"key":"7643_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123:1721\u20131730. https:\/\/doi.org\/10.1002\/cncr.30498","journal-title":"Cancer"},{"key":"7643_CR13","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/nejmsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PDP, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DGR, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer Risk. N Engl J Med 372:2243\u20132257. https:\/\/doi.org\/10.1056\/nejmsr1501341","journal-title":"N Engl J Med"},{"key":"7643_CR14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41588-018-0202-0","volume":"50","author":"C Turnbull","year":"2018","unstructured":"Turnbull C, Sud A, Houlston RS (2018) Cancer genetics, precision prevention and a call to action. Nat Genet 50:1212\u20131218","journal-title":"Nat Genet"},{"key":"7643_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.955","volume":"43","author":"T Rafnar","year":"2011","unstructured":"Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, Jonasdottir A, Besenbacher S, Lundin P, Stacey SN, Gudmundsson J, Magnusson OT, Le Roux L, Orlygsdottir G, Helgadottir HT, Johannsdottir H, Gylfason A, Tryggvadottir L, Jonasson JG, De Juan A, Ortega E, Ramon-Cajal JM, Garc\u00eda-Prats MD, Mayordomo C, Panadero A, Rivera F, Aben KKH, Van Altena AM, Massuger LFAG, Aavikko M, Kujala PM, Staff S, Aaltonen LA, Olafsdottir K, Bjornsson J, Kong A, Salvarsdottir A, Saemundsson H, Olafsson K, Benediktsdottir KR, Gulcher J, Masson G, Kiemeney LA, Mayordomo JI, Thorsteinsdottir U, Stefansson K (2011) Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet 43:1104\u20131107. https:\/\/doi.org\/10.1038\/ng.955","journal-title":"Nat Genet"},{"key":"7643_CR16","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1093\/hmg\/ddr229","volume":"20","author":"LM Pelttari","year":"2011","unstructured":"Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittom\u00e4ki K, B\u00fctzow R, Nevanlinna H (2011) RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet 20:3278\u20133288. https:\/\/doi.org\/10.1093\/hmg\/ddr229","journal-title":"Hum Mol Genet"},{"key":"7643_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/ng.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Eccles D, Evans DG, Renwick A, Seal S, Lord CJ, Ashworth A, Reis-Filho JS, Antoniou AC, Rahman N (2011) Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 43:879\u2013882. https:\/\/doi.org\/10.1038\/ng.893","journal-title":"Nat Genet"},{"key":"7643_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/ijms18020308","volume":"18","author":"R Kamps","year":"2017","unstructured":"Kamps R, Brand\u00e3o RD, van den Bosch BJ, Paulussen ADC, Xanthoulea S, Blok MJ, Romano A (2017) Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification. Int J Mol Sci 18:308","journal-title":"Int J Mol Sci"},{"key":"7643_CR19","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/ijc.32304","volume":"145","author":"L Feliubadal\u00f3","year":"2019","unstructured":"Feliubadal\u00f3 L, L\u00f3pez-Fern\u00e1ndez A, Pineda M, D\u00edez O, del Valle J, Guti\u00e9rrez-Enr\u00edquez S, Teul\u00e9 A, Gonz\u00e1lez S, Stjepanovic N, Salinas M, Capell\u00e1 G, Brunet J, L\u00e1zaro C, Balma\u00f1a J, Campos O, Carrasco E, Cuesta R, Darder E, Gadea N, G\u00f3mez C, Grau E, Iglesias S, Izquierdo A, Llort G, Men\u00e9ndez M, Moles-Fern\u00e1ndez A, Montes E, Mu\u00f1oz X, Navarro M, Ramon y Cajal T, Sanz J, Solanes A, Stradella A, Tornero E, Torres-Esquius S, Tuset N, Urgell G, Velasco A (2019) Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels. Int J Cancer 145:2682\u20132691. https:\/\/doi.org\/10.1002\/ijc.32304","journal-title":"Int J Cancer"},{"key":"7643_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12103046","volume":"12","author":"M Pavanello","year":"2020","unstructured":"Pavanello M, Chan IHY, Ariff A, Pharoah PDP, Gayther SA, Ramus SJ (2020) Rare germline genetic variants and the risks of epithelial ovarian cancer. Cancers (Basel) 12:1\u201323","journal-title":"Cancers (Basel)"},{"key":"7643_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ygyno.2011.02.010","volume":"121","author":"Z Ketabi","year":"2011","unstructured":"Ketabi Z, Bartuma K, Bernstein I, Malander S, Gr\u00f6nberg H, Bj\u00f6rck E, Holck S, Nilbert M (2011) Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors. Gynecol Oncol 121:462\u2013465. https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.010","journal-title":"Gynecol Oncol"},{"key":"7643_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10549-009-0634-4","volume":"123","author":"M Wasielewski","year":"2010","unstructured":"Wasielewski M, Riaz M, Vermeulen J, Van Den Ouweland A, Labrijn-Marks I, Olmer R, Van Der Spaa L, Klijn JGM, Meijers-Heijboer H, Dooijes D, Schutte M (2010) Association of rare MSH6 variants with familial breast cancer. Breast Cancer Res Treat 123:315\u2013320. https:\/\/doi.org\/10.1007\/s10549-009-0634-4","journal-title":"Breast Cancer Res Treat"},{"key":"7643_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/gim.2017.254","volume":"20","author":"ME Roberts","year":"2018","unstructured":"Roberts ME, Jackson SA, Susswein LR, Zeinomar N, Ma X, Marshall ML, Stettner AR, Milewski B, Xu Z, Solomon BD, Terry MB, Hruska KS, Klein RT, Chung WK (2018) MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genet Med 20:1167\u20131174. https:\/\/doi.org\/10.1038\/gim.2017.254","journal-title":"Genet Med"},{"key":"7643_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/S41431-020-00758-W","volume":"29","author":"G de Wert","year":"2021","unstructured":"de Wert G, Dondorp W, Clarke A, Dequeker EMC, Cordier C, Deans Z, van El CG, Fellmann F, Hastings R, Hentze S, Howard H, Macek M, Mendes A, Patch C, Rial-Sebbag E, Stefansdottir V, Cornel MC, Forzano F (2021) Opportunistic genomic screening. Recommendations of the European Society of Human Genetics. Eur J Hum Genet 29:365\u2013377. https:\/\/doi.org\/10.1038\/S41431-020-00758-W","journal-title":"Eur J Hum Genet"},{"key":"7643_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/JMG-2023-109389","volume":"61","author":"S Fern\u00e1ndez-Castillejo","year":"2023","unstructured":"Fern\u00e1ndez-Castillejo S, Roig B, Mel\u00e9 M, Serrano S, Salvat M, Querol M, Brunet J, Pineda M, Cisneros A, Parada D, Badia J, Borr\u00e0s J, Rodr\u00edguez-Balada M, Gum\u00e0 J (2023) Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer. J Med Genet 61:69\u201377. https:\/\/doi.org\/10.1136\/JMG-2023-109389","journal-title":"J Med Genet"},{"key":"7643_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3978\/j.issn.2305-5839.2015.08.11","volume":"3","author":"M Potrony","year":"2015","unstructured":"Potrony M, Badenas C, Aguilera P, Puig-Butille JA, Carrera C, Malvehy J, Puig S (2015) Update in genetic susceptibility in melanoma. Ann Transl Med 3:210. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.08.11","journal-title":"Ann Transl Med"},{"key":"7643_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/humu.22969","volume":"37","author":"LF Johansson","year":"2016","unstructured":"Johansson LF, van Dijk F, de Boer EN, van Dijk-Bos KK, Jongbloed JDH, van der Hout AH, Westers H, Sinke RJ, Swertz MA, Sijmons RH, Sikkema-Raddatz B (2016) CoNVaDING: single exon variation detection in targeted NGS data. Hum Mutat 37:457\u2013464. https:\/\/doi.org\/10.1002\/humu.22969","journal-title":"Hum Mutat"},{"key":"7643_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"7643_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1828","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res. https:\/\/doi.org\/10.1186\/bcr1828","journal-title":"Breast Cancer Res"},{"key":"7643_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/humu.1136","volume":"17","author":"A Vega","year":"2001","unstructured":"Vega A, Campos B, Bressac-de-Paillerets B, Bond PM, Janin N, Douglas FS, Dom\u00e8nech M, Baena M, Pericay C, Alonso C, Carracedo A, Baiget M, Diez O (2001) The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 17:520\u2013521. https:\/\/doi.org\/10.1002\/humu.1136","journal-title":"Hum Mutat"},{"key":"7643_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/NG1096-185","volume":"14","author":"BB Roa","year":"1996","unstructured":"Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185\u2013187. https:\/\/doi.org\/10.1038\/NG1096-185","journal-title":"Nat Genet"},{"key":"7643_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O D\u00edez","year":"2003","unstructured":"D\u00edez O, Osorio A, Dur\u00e1n M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodr\u00edguez-L\u00f3pez R, Velasco E, Chaves J, D\u00edaz-Rubio E, Jes\u00fas Cruz J, Torres M, Esteban E, Cervantes A, Alonso C, San Rom\u00e1n JM, Gonz\u00e1lez-Sarmiento R, Miner C, Carracedo A, Eugenia Armengod M, Cald\u00e9s T, Ben\u00edtez J, Baiget M (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301\u2013312. https:\/\/doi.org\/10.1002\/humu.10260","journal-title":"Hum Mutat"},{"key":"7643_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","volume":"13","author":"N Tung","year":"2016","unstructured":"Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, Offit K, Robson ME (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13:581\u2013588","journal-title":"Nat Rev Clin Oncol"},{"key":"7643_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12609-019-00339-x","volume":"11","author":"L Gonzalez","year":"2019","unstructured":"Gonzalez L, Kruper L (2019) Updates in genetic testing guidelines for breast cancer susceptibility genes: a change in the paradigm. Curr Breast Cancer Rep 11:358\u2013364","journal-title":"Curr Breast Cancer Rep"},{"key":"7643_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/JMEDGENET-2020-107347","volume":"59","author":"DG Evans","year":"2022","unstructured":"Evans DG, Van Veen EM, Byers HJ, Evans SJ, Burghel GJ, Woodward ER, Harkness EF, Eccles DM, Greville-Haygate SL, Ellingford JM, Bowers NL, Pereira M, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG, Smith MJ (2022) High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer. J Med Genet 59:115\u2013121. https:\/\/doi.org\/10.1136\/JMEDGENET-2020-107347","journal-title":"J Med Genet"},{"key":"7643_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-023-11229-Y","author":"A \u00d6fverholm","year":"2023","unstructured":"\u00d6fverholm A, T\u00f6rngren T, Ros\u00e9n A, Arver B, Einbeigi Z, Haraldsson K, St\u00e5hlbom AK, Kuchinskaya E, Lindblom A, Melin B, Paulsson-Karlsson Y, Stenmark-Askmalm M, Tham E, von Wachenfeldt A, Kvist A, Borg \u00c5, Ehrencrona H (2023) Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. https:\/\/doi.org\/10.1186\/S12885-023-11229-Y","journal-title":"BMC Cancer"},{"key":"7643_CR37","unstructured":"International Agency for Research in Cancer 2020 GLOBOCAN 2020. https:\/\/gco.iarc.fr\/. Accessed 17 Dec 2020"},{"key":"7643_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.CRITREVONC.2020.102989","author":"A Jeyakumar","year":"2020","unstructured":"Jeyakumar A, Chua T, Lam AKY, Gopalan V (2020) The Melanoma and breast cancer association: an overview of their \u201csecond primary cancers\u201d and the epidemiological, genetic and biological correlations. Crit Rev Oncol Hematol. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2020.102989","journal-title":"Crit Rev Oncol Hematol"},{"key":"7643_CR39","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/bjd.13626","volume":"172","author":"PV Gumaste","year":"2015","unstructured":"Gumaste PV, Penn LA, Cymerman RM, Kirchhoff T, Polsky D, McLellan B (2015) Skin cancer risk in BRCA1\/2 mutation carriers. Br J Dermatol 172:1498\u20131506. https:\/\/doi.org\/10.1111\/bjd.13626","journal-title":"Br J Dermatol"},{"key":"7643_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/pcmr.12833","volume":"33","author":"DJ Adams","year":"2020","unstructured":"Adams DJ, Bishop DT, Robles-Espinoza CD (2020) Melanoma predisposition\u2014A limited role for germline BRCA1 and BRCA2 variants. Pigment Cell Melanoma Res 33:6\u20137","journal-title":"Pigment Cell Melanoma Res"},{"key":"7643_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041007","author":"L Pastorino","year":"2020","unstructured":"Pastorino L, Andreotti V, Dalmasso B, Vanni I, Ciccarese G, Mandal\u00e0 M, Spadola G, Antonietta Pizzichetta M, Ponti G, Grazia Tibiletti M, Sala E, Genuardi M, Chiurazzi P, Maccanti G, Manoukian S, Sestini S, Danesi R, Zampiga V, La Starza R, Stanganelli I, Ballestrero A, Mastracci L, Grillo F, Sciallero S, Cecchi F, Teresa Tanda E, Spagnolo F, Queirolo P, Goldstein AM, Bruno W, Ghiorzo P (2020) Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12041007","journal-title":"Cancers (Basel)"},{"key":"7643_CR42","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/S41436-021-01240-8","volume":"23","author":"B Dalmasso","year":"2021","unstructured":"Dalmasso B, Pastorino L, Nathan V, Shah NN, Palmer JM, Howlie M, Johansson PA, Freedman ND, Carter BD, Beane-Freeman L, Hicks B, Molven A, Helgadottir H, Sankar A, Tsao H, Stratigos AJ, Helsing P, Van Doorn R, Gruis NA, Visser M, Wadt KAW, Mann G, Holland EA, Nagore E, Potrony M, Puig S, Menin C, Peris K, Fargnoli MC, Calista D, Soufir N, Harland M, Bishop T, Kanetsky PA, Elder DE, Andreotti V, Vanni I, Bruno W, H\u00f6iom V, Tucker MA, Yang XR, Andresen PA, Adams DJ, Landi MT, Hayward NK, Goldstein AM, Ghiorzo P (2021) Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia. Genet Med 23:2087\u20132095. https:\/\/doi.org\/10.1038\/S41436-021-01240-8","journal-title":"Genet Med"},{"key":"7643_CR43","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1001\/JAMAONCOL.2017.0769","volume":"3","author":"NJ Samadder","year":"2017","unstructured":"Samadder NJ, Smith KR, Wong J, Thomas A, Hanson H, Boucher K, Kopituch C, Cannon-Albright LA, Burt RW, Curtin K (2017) Cancer risk in families fulfilling the Amsterdam criteria for lynch syndrome. JAMA Oncol 3:1697\u20131701. https:\/\/doi.org\/10.1001\/JAMAONCOL.2017.0769","journal-title":"JAMA Oncol"},{"key":"7643_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/S41436-019-0596-9","volume":"22","author":"M Dominguez-Valentin","year":"2019","unstructured":"Dominguez-Valentin M, Sampson JR, Sepp\u00e4l\u00e4 TT, ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A, Lopez-K\u00f6stner F, Gluck N, Katz LH, Heinimann K, Vaccaro CA, B\u00fcttner R, G\u00f6rgens H, Holinski-Feder E, Morak M, Holzapfel S, H\u00fcneburg R, von Knebel Doeberitz M, Loeffler M, Rahner N, Schackert HK, Steinke-Lange V, Schmiegel W, Vangala D, Pylv\u00e4n\u00e4inen K, Renkonen-Sinisalo L, Hopper JL, Win AK, Haile RW, Lindor NM, Gallinger S, Le Marchand L, Newcomb PA, Figueiredo JC, Thibodeau SN, Wadt K, Therkildsen C, Okkels H, Ketabi Z, Moreira L, S\u00e1nchez A, Serra-Burriel M, Pineda M, Navarro M, Blanco I, Green K, Lalloo F, Crosbie EJ, Hill J, Denton OG, Frayling IM, R\u00f8dland EA, Vasen H, Mints M, Neffa F, Esperon P, Alvarez K, Kariv R, Rosner G, Pinero TA, Gonzalez ML, Kalfayan P, Tjandra D, Winship IM, Macrae F, M\u00f6slein G, Mecklin JP, Nielsen M, M\u00f8ller P (2019) Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genetics Med 22:15. https:\/\/doi.org\/10.1038\/S41436-019-0596-9","journal-title":"Genetics Med"},{"key":"7643_CR45","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/JAMA.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790\u20131795. https:\/\/doi.org\/10.1001\/JAMA.2009.1529","journal-title":"JAMA"},{"key":"7643_CR46","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jaad.2014.06.036","volume":"71","author":"M Potrony","year":"2014","unstructured":"Potrony M, Puig-Butill\u00e9 JA, Aguilera P, Badenas C, Carrera C, Malvehy J, Puig S (2014) Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling. J Am Acad Dermatol 71:888\u2013895. https:\/\/doi.org\/10.1016\/j.jaad.2014.06.036","journal-title":"J Am Acad Dermatol"},{"key":"7643_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","volume":"51","author":"H Helgadottir","year":"2014","unstructured":"Helgadottir H, H\u00f6iom V, J\u00f6nsson G, Tuominen R, Ingvar C, Borg A, Olsson H, Hansson J (2014) High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet 51:545\u2013552. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102320","journal-title":"J Med Genet"},{"key":"7643_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/ejhg.2010.198","volume":"19","author":"RR McWilliams","year":"2011","unstructured":"McWilliams RR, Wieben ED, Rabe KG, Pedersen KS, Wu Y, Sicotte H, Petersen GM (2011) Prevalence of CDKN2A mutations in pancreatic cancer patients: Implications for genetic counseling. Eur J Hum Genet 19:472\u2013478. https:\/\/doi.org\/10.1038\/ejhg.2010.198","journal-title":"Eur J Hum Genet"},{"key":"7643_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/JGC4.1075","volume":"28","author":"S Makhnoon","year":"2019","unstructured":"Makhnoon S, Shirts BH, Bowen DJ (2019) Patients\u2019 perspectives of variants of uncertain significance and strategies for uncertainty management. J Genet Couns 28:313\u2013325. https:\/\/doi.org\/10.1002\/JGC4.1075","journal-title":"J Genet Couns"},{"key":"7643_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/S12687-019-00434-7","volume":"11","author":"K Clift","year":"2020","unstructured":"Clift K, Macklin S, Halverson C, McCormick JB, Abu Dabrh AM, Hines S (2020) Patients\u2019 views on variants of uncertain significance across indications. J Community Genet 11:139\u2013145. https:\/\/doi.org\/10.1007\/S12687-019-00434-7","journal-title":"J Community Genet"},{"key":"7643_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/S41436-020-00957-2","volume":"23","author":"C Mighton","year":"2021","unstructured":"Mighton C, Shickh S, Uleryk E, Pechlivanoglou P, Bombard Y (2021) Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis. Genet Med 23:22\u201333. https:\/\/doi.org\/10.1038\/S41436-020-00957-2","journal-title":"Genet Med"},{"key":"7643_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ejmg.2017.07.016","volume":"60","author":"DF Vears","year":"2017","unstructured":"Vears DF, S\u00e9n\u00e9cal K, Borry P (2017) Reporting practices for variants of uncertain significance from next generation sequencing technologies. Eur J Med Genet 60:553\u2013558. https:\/\/doi.org\/10.1016\/j.ejmg.2017.07.016","journal-title":"Eur J Med Genet"},{"key":"7643_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-020-01554-6","volume":"39","author":"G Federici","year":"2020","unstructured":"Federici G, Soddu S (2020) Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers. J Exp Clin Cancer Res 39:46","journal-title":"J Exp Clin Cancer Res"},{"key":"7643_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-0935-9","author":"N Weber-Lassalle","year":"2018","unstructured":"Weber-Lassalle N, Hauke J, Ramser J, Richters L, Gro\u00df E, Bl\u00fcmcke B, Gehrig A, Kahlert AK, M\u00fcller CR, Hackmann K, Honisch E, Weber-Lassalle K, Niederacher D, Borde J, Thiele H, Ernst C, Altm\u00fcller J, Neidhardt G, N\u00fcrnberg P, Klaschik K, Schroeder C, Platzer K, Volk AE, Wang-Gohrke S, Just W, Auber B, Kubisch C, Schmidt G, Horvath J, Wappenschmidt B, Engel C, Arnold N, Dworniczak B, Rhiem K, Meindl A, Schmutzler RK, Hahnen E (2018) BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer. Breast Cancer Res. https:\/\/doi.org\/10.1186\/s13058-018-0935-9","journal-title":"Breast Cancer Res"},{"key":"7643_CR55","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/JNCI\/DJY106","volume":"110","author":"H Shimelis","year":"2018","unstructured":"Shimelis H, LaDuca H, Hu C, Hart SN, Na J, Thomas A, Akinhanmi M, Moore RM, Brauch H, Cox A, Eccles DM, Ewart-Toland A, Fasching PA, Fostira F, Garber J, Godwin AK, Konstantopoulou I, Nevanlinna H, Sharma P, Yannoukakos D, Yao S, Feng BJ, Davis BT, Lilyquist J, Pesaran T, Goldgar DE, Polley EC, Dolinsky JS, Couch FJ (2018) Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing. J Natl Cancer Inst 110:855\u2013862. https:\/\/doi.org\/10.1093\/JNCI\/DJY106","journal-title":"J Natl Cancer Inst"},{"key":"7643_CR56","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/JNCI\/DJAA023","volume":"112","author":"C Hu","year":"2020","unstructured":"Hu C, Polley EC, Yadav S, Lilyquist J, Shimelis H, Na J, Hart SN, Goldgar DE, Shah S, Pesaran T, Dolinsky JS, Laduca H, Couch FJ (2020) The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort. J Natl Cancer Inst 112:1231\u20131241. https:\/\/doi.org\/10.1093\/JNCI\/DJAA023","journal-title":"J Natl Cancer Inst"},{"key":"7643_CR57","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1200\/jco.1996.14.5.1730","volume":"14","author":"S Beckhardt","year":"1996","unstructured":"Beckhardt S (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 14:1730\u20131736. https:\/\/doi.org\/10.1200\/jco.1996.14.5.1730","journal-title":"J Clin Oncol"},{"key":"7643_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","volume":"18","author":"MB Daly","year":"2020","unstructured":"Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD (2020) Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020 featured updates to the NCCN guidelines. JNCCN J Natl Compr Cancer Netw 18:380\u2013391. https:\/\/doi.org\/10.6004\/jnccn.2020.0017","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"7643_CR59","doi-asserted-by":"publisher","DOI":"10.1200\/po.18.00217","author":"GE Idos","year":"2019","unstructured":"Idos GE, Kurian AW, Ricker C, Sturgeon D, Culver JO, Kingham KE, Koff R, Chun NM, Rowe-Teeter C, Lebensohn AP, Levonian P, Lowstuter K, Partynski K, Hong C, Mills MA, Petrovchich I, Ma CS, Hartman A-R, Allen B, Wenstrup RJ, Lancaster JM, Brown K, Kidd J, Evans B, Mukherjee B, McDonnell KJ, Ladabaum U, Ford JM, Gruber SB (2019) Multicenter prospective cohort study of the diagnostic yield and patient experience of multiplex gene panel testing for hereditary cancer risk. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/po.18.00217","journal-title":"JCO Precis Oncol"},{"key":"7643_CR60","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ejhg.2015.268","volume":"24","author":"AH Petersen","year":"2016","unstructured":"Petersen AH, Aagaard MM, Nielsen HR, Steffensen KD, Waldstr\u00f8m M, Bojesen A (2016) Post-mortem testing; germline BRCA1\/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling. Eur J Hum Genet 24:1104\u20131111. https:\/\/doi.org\/10.1038\/ejhg.2015.268","journal-title":"Eur J Hum Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07643-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:45:53Z","timestamp":1743381953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07643-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7643"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07643-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}